A Bioavailability Study With Alternate Methods of Administration of Naloxegol Tablets, and Solution

NCT02446171 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioavailability
Healthy Subjects

Interventions

DRUG: Naloxegol 25 mg tablet, crushed, suspended in water, given orally
DRUG: Naloxegol 25mg tablet crushed, suspended in water, given via nasogastric tube
DRUG: Naloxegol 25 mg (10 mL oral solution)
DRUG: Naloxegol 25 mg tablet, given orally

Sponsor

AstraZeneca